Cardiovascular disease (general) Clinical Trials
Recruiting cardiovascular disease (general) studies with sites across the US, sourced from ClinicalTrials.gov and refreshed daily. Free to join — find one near you below.
Clinical trials study new ways to prevent, detect, or treat cardiovascular disease (general). Joining one can give you access to investigational treatments and close monitoring by a specialist research team — at no cost — while helping advance care for others. Below are recruiting cardiovascular disease (general) studies with sites across the US; use the location tools to find ones near you.
What to expect
- Screening first. The study team reviews your eligibility before anything else — there's no obligation to continue.
- Informed consent. You'll get a full explanation of the study, its potential risks and benefits, and can withdraw at any time.
- No cost to you. Study visits, tests, and the investigational treatment are covered; many studies reimburse travel.
Recruiting cardiovascular disease (general) trials
TA-65 and Aging Associated Microvascular Dysfunction
VITAL-IMPACT: Improving Cardiometabolic Health in Black Individuals Through Therapeutic Augmentation of Cyclic Guanosine Mono-Phosphate Signaling Pathway
Enhancing Mental and Physical Health of Women Veterans 3.0
Estrogen Deficiency on Cardiovascular Risk
Impact of Combined Cardio-pulmonary Assessment on COPD Clinical Management.
Impact of Transcutaneous Spinal Stimulation on Blood Pressure and Orthostasis in Spinal Cord Injury
Dietary Supplements in Patients With Coronary Artery Bypass Grafting for Improving the Quality of Healthcare Delivery.
WomenFocused Education in CArdiac REhabilitation (WECARE) Pilot RCT
A Prospective, Randomized Multicenter Clinical Trial of the TricValve® Transcatheter Bicaval Valve System in Subjects With Severe Tricuspid Regurgitation.
Evaluation of a Novel Indoor Air Pollution Intervention Among Older Adults
Evaluation of Anxiety Reduction in the Cathlab by Means of Pharmacological and Non-pharmacological Strategies
TRIFORMIS RESILIA Real-world Study Assessing Safety and Performance (TRIBLAZE Study)
A Study Exploring the Effect of Adjuvanted RZV or RSVPreF3 Vaccines on Coronary Plaque Progression in Adults >=50 Years of Age at Risk for Cardiovascular Events
Palmitic Acid and Human Microvascular Function
Free Fatty Acid Effects In Type 2 Diabetes
Supporting Mental Health and Reducing Care Stress in Caregivers of Persons With Cardiovascular Disease
A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease
Screening for Social Determinants of Health (SDOH) and Cognitive Function in Individuals With History of Stroke
Fibrotic Disease Activity in Cardiopulmonary Disorders Using 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) PET/CT Imaging
Pilot Study to Evaluate a Noninvasive Electrocardiographic Monitoring Strategy Associated With Early Discharge in Patients With Conduction Disorders Following TAVI Implantation (IMPROVE Study)
Optimizing Cardiovascular Preventive Care for Women Following Hypertensive Disorders of Pregnancy
In-Hospital Wearable-Based Monitoring Versus Standard Care in Cardiovascular Disease (INSPIRE)
Association Between 4D MRI Parameters and the Clinical Characteristics and Prognosis of Major Chronic Diseases
Study on Intervention Effect of Heat-related Health Risk Early Warning Digital Technology for School-age Children
Efficacy and Safety of Antihypertensive Treatment With Mobile Stroke Units in Ultra-Early Intracerebral Hemorrhage
Risk Prediction Scores for Cardiotoxicity in Cancer Patients Treated With Cardiotoxic Anticancer Therapies in Europe
Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold (RMS) System in Subjects With Coronary Artery Lesions
Health Ahead Comparative Effectiveness Study
Effect of Visual Presentation of Atherosclerotic Plaque on Modification of Arterial Hypertension One Year Postpartum in Women With a History of Adverse Pregnancy Outcomes, and Risk Customization With AI Prediction Algorithms
Exercise Activity Intervention With Sensor-Based Engagement in Patients With Atrial Fibrillation
A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk
A Cluster Randomized Trial of a Telemedicine-Enabled Integrated Care Model for Stroke Prevention and Management in Rural Elderly Adults in China
BAG3-DCM Natural History Study
Effectiveness of Pollution Monitoring in Clinical Exercise Rehabilitation
Moderate-Intensity Statin Plus Ezetimibe in CKD and ASCVD
Measurements Before and After Participation in a Health Intervention Programme in Halsnaes Municipality
Regional Innovation in Chronic Disease and Elderly Care
Comparative Study on the Mode of Action of Vicadrostat and Spironolactone on Protein Profiles and Renal Hemodynamic Effects (COMPARE-VS)
Artificial Intelligence Delivered Cardiac Magnetic Resonance - Prospective Validation
Vital Signs Blood Pressure Trial
Innovative Sternal Closure Techniques: Evaluating STRATAFIX™ and DERMABOND™ for Reduced Complications in CABG Patients
Longitudinal Validation of CIRC Technologies
The Effect of Dapagliflozin on Exercise and Cardiac Functional Status of Patients After Fontan Procedure
Recombinant Herpes Zoster Vaccine for Prevention of Cardiovascular Events and Dementia
Human Observatory Study
Feasibility of The Health Integrated Nutrition and Kidney Wellness Program
The PreEclampsia Postpartum Prevention Trial
Stress Reactivity and Mother-Infant Cardiovascular Disease Risk
Awareness of Risk Factors and Perception of Cardiovascular Risk in Secondary Prevention Among Women and Men
Self Expanding Coronary Sinus Reducer for Treatment of Symptomatic Coronary Microvascular Dysfunction (CMD)
Effect of Neurofast® Supplementation on Anxiety and Cardiovascular Outcomes in the Psycho-Cardio Phenotype Adults
Fascial Plane Blocks and Quality of Recovery in Cardiac Surgery
A Real-World Study of Long-Term Adherence and Persistence to Inclisiran, Evolocumab, and Alirocumab
AI-Based Phenome Data Analysis for Predicting the Onset of Major Diseases
SMART to Optimize an Intervention to Maintain Health Improvements After Cardiac Rehabilitation
PKP2-ACM Natural History Study
Vbeam Pro Pulse Dye Laser for the Treatment of Vascular Conditions
DECODE - Haemodynamic Effects Of Semaglutide and Tirzepatide - a Series of Pilot Studies
A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors
Cardiovascular disease (general) clinical trials — common questions
Are cardiovascular disease (general) clinical trials free to join?
Yes. Participating in a cardiovascular disease (general) clinical trial is free — study-related visits, tests, and the investigational treatment are provided at no cost to you. Many studies also reimburse travel and time. You never pay to take part.
Who can join a cardiovascular disease (general) clinical trial?
Each cardiovascular disease (general) study sets its own eligibility criteria — typically based on age, medical history, current treatments, and overall health. Every trial listed here shows its criteria, and the study team confirms your eligibility before enrollment. You can review and apply to any that look like a fit.
How do I find a cardiovascular disease (general) trial near me?
Use the location controls above. We'll show recruiting cardiovascular disease (general) trials with sites near you, sorted by distance. You can widen the radius or share your exact location for the closest matches.
How many cardiovascular disease (general) trials are recruiting right now?
We're currently tracking roughly 211 recruiting cardiovascular disease (general) trials with US sites, sourced from ClinicalTrials.gov and refreshed daily.
Looking for a specific location? Browse trials by city and state.